Renuka Jain, MD
Cardiovascular Disease · Milwaukee, WINPI 1811037161
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 92.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $39,094 and has fallen 58.5% since, to $16,214 in 2025. Among cardiovascular disease clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 325 payments — averaging $401.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$120K
- Abbott$3K
- Edwards Lifesciences$2K
- Ancora Heart, Inc.$2K
- Philips North America LLC$2K
- Boston Scientific$279
- plus $440 from 5 others
Across 44 payments — averaging $4751.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GE HealthCare$89K
- Medtronic$78K
- Philips North America LLC$42K
What the payments were for
- Consulting fees$24,42219%
- Speaking & faculty fees$57,83844%
- Travel & lodging$38,41729%
- Food & beverage$9,9548%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 263 | $120,219 |
| Abbott | 26 | $3,133 |
| Edwards Lifesciences | 17 | $2,398 |
| Ancora Heart, Inc. | 6 | $2,209 |
| Philips North America LLC | 2 | $1,954 |
| Boston Scientific | 4 | $279 |
| Siemens Medical Solutions USA, Inc. | 1 | $137 |
| Heartflow, Inc. | 1 | $136 |
| GE HealthCare | 2 | $112 |
| AstraZeneca | 2 | $42 |
| Neos Therapeutics, LP | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$61,957
- CoreValve Evolut$13,839
- AccuCinch$2,199
- (1667) Ultrasound Options and Upgrades$1,925
- Mitra Clip system$1,472
- Edwards SAPIEN 3 Transcatheter Heart Valve$489
- MitraClip System$334
- Avalus$167
- MitraClip$154
- WATCHMAN Access System$137
- HeartMate 3 Left Ventricular Dev$137
- APOLLOTM$122
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$120
- GENERAL - STRUCTURAL HEART$115
How this compares
$130,630 in reported general payments places this provider in the 95th percentile of 322 cardiovascular disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Milwaukee
- Lee BibloMilwaukee$280K
- David GrambowMilwaukee$267K
- Eric RobertsMilwaukee$131K
- Evgenia RaichlinMilwaukee$73K
- Prakash ShahMilwaukee$51K
- Sisir SiddamsettiMilwaukee$44K
- Manmeet SinghMilwaukee$39K
- Jordan SwisherMilwaukee$36K
- Christian BreburdaMilwaukee$35K
- Marc AtzenhoeferMilwaukee$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.